Savient Pharma (SVNT) Shares Nosedive as Co. Served with Credit Derivative Action
Tweet
Share
E-mailGet Alerts SVNT Hot Sheet
Join SI Premium – FREE
Shares of Savient Pharma (Nasdaq: SVNT) are plunging midday Tuesday following an 8-K filing which disclosed the company was served with a creditor derivative action. The complaint was filed by Tang Capital.
The stock is now down a whopping 28 percent to around $1.71.
The stock is now down a whopping 28 percent to around $1.71.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
- Nuvectis Pharma (NVCT) files $200M mixed shelf
Create E-mail Alert Related Categories
Corporate News, Momentum MoversRelated Entities
Tang CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
